A number of compounds targeting different processes of the Human Immunodeficiency Virus type 1 (HIV-1) life cycle have been developed in the continuing fight against AIDS. Coumarin-based molecules already proved to act as HIV-1 Protease (PR) or Integrase (IN) inhibitors and also to target HIV-1 reverse transcriptase (RT), blocking the DNA-dependent DNA-polymerase activity or the RNA-dependent DNA-polymerase activity working as common NNRTIs. In the present study, with the aim to exploit a coumarin-based scaffold to achieve the inhibition of multiple viral coded enzymatic functions, novel 4-hydroxy-2H, 5H-pyrano (3, 2-c) chromene-2, 5-dione derivatives were synthesized. The modeling studies calculated the theoretical binding affinity of the synthesized compounds on both HIV-1 IN and RT-associated Ribonuclease H (RNase H) active sites, which was confirmed by biological assays. Our results provide a basis for the identification of dual HIV-1 IN and RT RNase H inhibitors compounds.
Chromenone derivatives as a versatile scaffold with dual mode of inhibition of HIV-1 reverse transcriptase-associated Ribonuclease H function and integrase activity.
F. Esposito,F. A. Ambrosio,Rita Maleddu,Giosuè Costa,R. Rocca,E. Maccioni,Raffaella Catalano,I. Romeo,P. Eleftheriou,Denish C. Karia,Petros Tsirides,N. Godvani,Hetal Pandya,A. Corona,S. Alcaro,A. Artese,A. Geronikaki,E. Tramontano
Published 2019 in European journal of medicinal chemistry
ABSTRACT
PUBLICATION RECORD
- Publication year
2019
- Venue
European journal of medicinal chemistry
- Publication date
2019-08-12
- Fields of study
Medicine, Chemistry
- Identifiers
- External record
- Source metadata
Semantic Scholar, PubMed
CITATION MAP
EXTRACTION MAP
CLAIMS
- No claims are published for this paper.
CONCEPTS
- No concepts are published for this paper.
REFERENCES
Showing 1-67 of 67 references · Page 1 of 1
CITED BY
Showing 1-32 of 32 citing papers · Page 1 of 1